Clinical Scorecard: Comprehensive Review of Recent Randomized Controlled Trials on Chronic Subdural Hematoma Management
At a Glance
Category
Detail
Condition
Chronic subdural haematoma (CSDH)
Key Mechanisms
Accumulation of blood in the subdural space, commonly in elderly patients, leading to neurological symptoms
Target Population
Primarily elderly patients with symptomatic CSDH
Care Setting
Neurosurgical and clinical settings involving surgical and non-surgical management
Key Highlights
Surgical burr hole evacuation with postoperative drainage remains the most common treatment for symptomatic CSDH.
Recent RCTs have shown inferior outcomes with dexamethasone, leading to decreased steroid use in clinical practice.
There is significant variability in surgical techniques and a lack of consensus on optimal management, highlighting the need for further high-quality research.
Guideline-Based Recommendations
Diagnosis
Diagnosis primarily based on clinical presentation and imaging confirming subdural hematoma.
Management
Surgical intervention with burr hole evacuation and postoperative drainage is standard for symptomatic cases.
Avoid routine use of steroids such as dexamethasone due to evidence of inferior outcomes.
Consider alternative treatments including craniotomy, pharmacological agents (e.g., tranexamic acid, statins), middle meningeal artery embolisation (MMAE), or watchful waiting based on clinical presentation.
Monitoring & Follow-up
Postoperative monitoring for recurrence and complications is essential.
Ongoing assessment of neurological status and imaging follow-up as indicated.
Risks
Variability in surgical technique may impact outcomes.
Use of steroids like dexamethasone is associated with poorer outcomes.
Risks related to surgical intervention include recurrence and procedural complications.
Patient & Prescribing Data
Elderly patients with symptomatic chronic subdural haematoma
Steroid use, particularly dexamethasone, is discouraged due to inferior outcomes demonstrated in RCTs; emerging pharmacological treatments and minimally invasive procedures are under investigation.
Clinical Best Practices
Employ burr hole evacuation with postoperative drainage as first-line surgical treatment for symptomatic CSDH.
Avoid dexamethasone as adjunct or alternative therapy based on recent RCT evidence.
Tailor treatment approach considering patient-specific factors and clinical presentation, including consideration of minimally invasive options like MMAE.
Adhere to updated clinical practice guidelines while recognizing current evidence limitations.
Encourage participation in ongoing RCTs to address knowledge gaps and improve evidence-based care.
Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.
